Fundz

Imvax, Inc. reported raising $112 Million in an initial SEC Form D filing, from an offering of $112 Million

PRIVATEJul 30, 2020

Amount Raised

$112 Million

$112 Million sold, per SEC Form D (first sale Jul 30, 2020)

Round Type

Venture

PhiladelphiaBiotechnology

Quick answer

Imvax raised $112 Million in a funding round, dated July 30, 2020. Imvax is based in Philadelphia, Pennsylvania, United States.

How much did Imvax raise?
Imvax raised $112 Million in a funding round on July 30, 2020.
What does Imvax do?
Imvax is a clinical-stage biotechnology company with a unique platform technology, Goldspire™, focused on delivering personalized, whole tumor-derived immunotherapies across a range of solid tumors.
Where is Imvax based and how big is it?
Imvax is based in Philadelphia, Pennsylvania, United States. Fundz records about 48 employees.
Who are the decision-makers at Imvax?
Fundz holds 1 contact at Imvax. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Imvax that raised within 45 days of this round, from Fundz verified event records.

  • Serimmune Inc. raised $12M on September 11, 2020.
  • THE TRŪ® SHRIMP COMPANIES raised $4M (Seed) on September 11, 2020.
  • Metabolon raised $22M on September 11, 2020.
  • Solarea Bio raised $11M on September 11, 2020.
  • Basking Biosciences raised $55M (Seed) on September 10, 2020.
  • Casma Therapeutics raised $50M (Series B) on September 10, 2020.

Who to call at Imvax, and when

A new round usually means Imvax is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Imvax raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Imvax, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Imvax. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Imvax

Location

Philadelphia, Pennsylvania, United States

About

Imvax is a clinical-stage biotechnology company with a unique platform technology, Goldspire™, focused on delivering personalized, whole tumor-derived immunotherapies across a range of solid tumors. Imvax’s most advanced program, IGV-001, is currently being evaluated in a Phase 2b clinical trial in newly diagnosed glioblastoma patients. Imvax’s portfolio also includes several other programs designed to stimulate a patient’s immune system against the entire antigen signature of their tumor. Imvax is headquartered in Philadelphia, PA.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Imvax raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts20 people are listed at Imvax. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Imvax's next move

See what Strategic adds

Imvax raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.